Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(26 sites)
China
Anhui Children's Hospital, Hefei, Anhui Children's Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality Fujian Children's Hospital, Fuzhou, Fujian People's Liberation Army Joint Logistics Force No. 900 Hospital, Fuzhou, Fujian The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Hebei Children's Hospital, Shijiazhuang, Hebei Harbin Children's Hospital, Harbin, Heilongjiang The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Henan Children's Hospital, Zhengzhou, Henan The First Affliated Hospital of Zhengzhou University, Zhengzhou, Henan Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Hunan Children's Hospital, Changsha, Hunan Children's Hospital of Soochow University, Suzhou, Jiangsu Baiqiu'en First Hospital of Jilin University, Changchun, Jilin Dalian Women and Children's Medical Centre, Dalian, Liaoning Shengjing Hospital of China Medical University, Shenyang, Liaoning Shandong Provincial Hospital, Jinan, Shandong Shanghai Children's Hospital, Shanghai, Shanghai Municipality Shanxi Children's Hospital, Taiyuan, Shanxi West China Second Hospital of Sichuan University, Chengde, Sichuan Chengdu Women's and Children's Central Hospital, Chengdu, Sichuan Tianjin Children's Hospital, Tianjin, Tianjin Municipality Xinjiang Uiger Municipal People's Hospital, Ürümqi, Xinjiang Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Ningbo Women's and Children's Hospital, Ningbo, Zhejiang